| 6. Human Diseases |
6.12 Drug resistance: Antineoplastic |
hsa01522 |
Endocrine resistance |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04010 |
MAPK signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04014 |
Ras signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04020 |
Calcium signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04024 |
cAMP signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04062 |
Chemokine signaling pathway |
| 4. Cellular Processes |
4.2 Cell growth and death |
hsa04114 |
Oocyte meiosis |
| 4. Cellular Processes |
4.1 Transport and catabolism |
hsa04140 |
Autophagy - animal |
| 5. Organismal Systems |
5.9 Aging |
hsa04211 |
Longevity regulating pathway |
| 5. Organismal Systems |
5.9 Aging |
hsa04213 |
Longevity regulating pathway - multiple species |
| 5. Organismal Systems |
5.3 Circulatory system |
hsa04261 |
Adrenergic signaling in cardiomyocytes |
| 5. Organismal Systems |
5.3 Circulatory system |
hsa04270 |
Vascular smooth muscle contraction |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04310 |
Wnt signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04340 |
Hedgehog signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04371 |
Apelin signaling pathway |
| 4. Cellular Processes |
4.3 Cellular community - eukaryotes |
hsa04530 |
Tight junction |
| 4. Cellular Processes |
4.3 Cellular community - eukaryotes |
hsa04540 |
Gap junction |
| 5. Organismal Systems |
5.1 Immune system |
hsa04611 |
Platelet activation |
| 5. Organismal Systems |
5.10 Environmental adaptation |
hsa04713 |
Circadian entrainment |
| 5. Organismal Systems |
5.10 Environmental adaptation |
hsa04714 |
Thermogenesis |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04720 |
Long-term potentiation |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04723 |
Retrograde endocannabinoid signaling |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04724 |
Glutamatergic synapse |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04725 |
Cholinergic synapse |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04726 |
Serotonergic synapse |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04727 |
GABAergic synapse |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04728 |
Dopaminergic synapse |
| 5. Organismal Systems |
5.7 Sensory system |
hsa04740 |
Olfactory transduction |
| 5. Organismal Systems |
5.7 Sensory system |
hsa04742 |
Taste transduction |
| 5. Organismal Systems |
5.7 Sensory system |
hsa04750 |
Inflammatory mediator regulation of TRP channels |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04910 |
Insulin signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04911 |
Insulin secretion |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04912 |
GnRH signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04913 |
Ovarian steroidogenesis |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04914 |
Progesterone-mediated oocyte maturation |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04915 |
Estrogen signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04916 |
Melanogenesis |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04918 |
Thyroid hormone synthesis |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04919 |
Thyroid hormone signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04921 |
Oxytocin signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04922 |
Glucagon signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04923 |
Regulation of lipolysis in adipocytes |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04924 |
Renin secretion |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04925 |
Aldosterone synthesis and secretion |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04926 |
Relaxin signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04927 |
Cortisol synthesis and secretion |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04928 |
Parathyroid hormone synthesis, secretion and action |
| 6. Human Diseases |
6.7 Endocrine and metabolic diseases |
hsa04934 |
Cushing syndrome |
| 5. Organismal Systems |
5.5 Excretory system |
hsa04961 |
Endocrine and other factor-regulated calcium reabsorption |
| 5. Organismal Systems |
5.5 Excretory system |
hsa04962 |
Vasopressin-regulated water reabsorption |
| 5. Organismal Systems |
5.4 Digestive system |
hsa04970 |
Salivary secretion |
| 5. Organismal Systems |
5.4 Digestive system |
hsa04971 |
Gastric acid secretion |
| 5. Organismal Systems |
5.4 Digestive system |
hsa04976 |
Bile secretion |
| 6. Human Diseases |
6.4 Neurodegenerative diseases |
hsa05012 |
Parkinson disease |
| 6. Human Diseases |
6.4 Neurodegenerative diseases |
hsa05020 |
Prion diseases |
| 6. Human Diseases |
6.5 Substance dependence |
hsa05030 |
Cocaine addiction |
| 6. Human Diseases |
6.5 Substance dependence |
hsa05031 |
Amphetamine addiction |
| 6. Human Diseases |
6.5 Substance dependence |
hsa05032 |
Morphine addiction |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05110 |
Vibrio cholerae infection |
| 6. Human Diseases |
6.10 Infectious diseases: Parasitic |
hsa05146 |
Amoebiasis |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05163 |
Human cytomegalovirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05165 |
Human papillomavirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05166 |
Human T-cell leukemia virus 1 infection |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05200 |
Pathways in cancer |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05203 |
Viral carcinogenesis |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05205 |
Proteoglycans in cancer |
| 6. Human Diseases |
6.6 Cardiovascular diseases |
hsa05414 |
Dilated cardiomyopathy (DCM) |